new molecules and indications for glp-1 medicines The Multifaceted Nature of GLP-1: Molecular Mechanisms Signaling Pathways in Metabolic and Neurodegenerative Diseases GLP-1 Receptor Agonists | New

Gut microbiome modulation : Early research suggests that GLP-1 receptor agonists like semaglutide may influence gut microbiota composition, though the clinical significance remains unclear and evidence is limited

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for the treatment of type 2 diabetes mellitus and chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity

Read more Cells in the body remember obesity

For instance, Ozempic, which is technically for diabetes but often used off label for weight loss, faces over $2 billion in lawsuits relating to undisclosed side effects

When patients lose a substantial amount of weight on GLP-1s, they experience volume loss in these facial fat pads and appear sunken in, often looking older than their actual age